Literature DB >> 7668835

Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.

B O Osuntokun1, A Sahota, A O Ogunniyi, O Gureje, O Baiyewu, A Adeyinka, S O Oluwole, O Komolafe, K S Hall, F W Unverzagt.   

Abstract

As part of a community-based study of Alzheimer's Disease (AD) in a Nigerian population aged 65 years and over, we have determined apolipoprotein E (APOE) genotypes on 56 subjects (39 controls and 17 subjects with dementia, including 12 with AD). The epsilon 4 allele of APOE was not associated with AD or dementia in this community-based sample. The epsilon 4 allele frequency was 17.6% in demented patients and 16.7% in AD patients compared with 20.5% in the control subjects. These findings are in marked contrast to the strong association between the epsilon 4 allele and AD in our previously reported study with African Americans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668835     DOI: 10.1002/ana.410380319

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  31 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.

Authors:  K Hall; J Murrell; A Ogunniyi; M Deeg; O Baiyewu; S Gao; O Gureje; J Dickens; R Evans; V Smith-Gamble; F W Unverzagt; J Shen; H Hendrie
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

Review 3.  Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.

Authors:  Alain Lekoubou; Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  BMC Public Health       Date:  2014-06-26       Impact factor: 3.295

4.  Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.

Authors:  Jessica B S Langbaum; Kewei Chen; Richard J Caselli; Wendy Lee; Cole Reschke; Daniel Bandy; Gene E Alexander; Christine M Burns; Alfred W Kaszniak; Stephanie A Reeder; Jason J Corneveaux; April N Allen; Jeremy Pruzin; Matthew J Huentelman; Adam S Fleisher; Eric M Reiman
Journal:  Arch Neurol       Date:  2010-04

Review 5.  Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator.

Authors:  R Katzman; D Kang; R Thomas
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

6.  Apolipoprotein E Genotypes, Age, Race, and Cognitive Decline in a Population Sample.

Authors:  Kumar B Rajan; Lisa L Barnes; Robert S Wilson; Jennifer Weuve; Elizabeth A McAninch; Denis A Evans
Journal:  J Am Geriatr Soc       Date:  2018-12-24       Impact factor: 5.562

7.  APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians.

Authors:  Oye Gureje; Adesola Ogunniyi; Olusegun Baiyewu; Brandon Price; Frederick W Unverzagt; Rebecca M Evans; Valerie Smith-Gamble; Kathleen A Lane; Sujuan Gao; Kathleen S Hall; Hugh C Hendrie; Jill R Murrell
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

8.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Authors:  M X Tang; G Maestre; W Y Tsai; X H Liu; L Feng; W Y Chung; M Chun; P Schofield; Y Stern; B Tycko; R Mayeux
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

Review 9.  Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E.

Authors:  N Nathoo; R Chetty; J R van Dellen; G H Barnett
Journal:  Mol Pathol       Date:  2003-06

10.  A comparative study to screen dementia and APOE genotypes in an ageing East African population.

Authors:  Chien-Hsiun Chen; Toshiki Mizuno; Robert Elston; Monica M Kariuki; Kathleen Hall; Fred Unverzagt; Hugh Hendrie; Samuel Gatere; Paul Kioy; Nilesh B Patel; Robert P Friedland; Raj N Kalaria
Journal:  Neurobiol Aging       Date:  2008-08-13       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.